Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluid Therapy Goals in Colorectal Surgery
NCT03677622Completed
- Sponsor
- Holbæk Hospital
- Start
- Mar 2008
- Primary completion
- Jul 2009
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
01
Overview
Randomised, double-blind trial of hetastarch in colorectal cancer (CRC) and Colorectal disease, sponsored by Holbæk Hospital. Primary endpoint: Composite of postoperative complications and death at 30 days. Started Mar 2008; status: completed.
02
Drugs
hetastarch
03
Conditions
colorectal cancer (CRC)Colorectal disease
Beyond the preview
Go deeper on NCT03677622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677622.